Umbilical cord blood not suitable for assessing allergy risk

Oct 05, 2010

For years, hospitals and researchers have been testing blood samples from the umbilical cords of newborn babies to assess the risk of allergy. Now a study at the University of Copenhagen has revealed that the biomarker in the blood that indicates the risk factor for allergy often comes from the mother rather than her baby.

Allergies occur when the defence mechanisms of the immune system malfunction and misread normal substances entering the body as invading pathogens. Antibodies are part of our biochemical arsenal for combating viruses, bacteria, parasites and other alien substances, but during an allergic reaction the antibody, known as IgE, is directed against usually harmless substances such as grass pollen, nuts, pets or eggs. Asthma and allergies are that reduce quality of life and pose an economic burden on society. New parents have therefore previously been asked if they would like hospitals to assess the risk their babies run of developing allergies in childhood. Hospitals tests the risk by measuring the amount of IgE in the blood of the . The results are then used to determine the need for prophylaxis, e.g. whether babies need a special allergy-friendly milk substitute.

The originates from the mother

However, researchers from COPSAC (Copenhagen Studies on Asthma in Childhood) at the Faculty of Health Sciences, University of Copenhagen recently discovered indications that IgE in the blood of the umbilical cord could originate from the mother, and decided to conduct a focused study on this.

They measured the total amount if IgE in the blood of the umbilical cord in 243 new-borns. The researchers subsequently determined how much IgE originated from the mother by using hypersensitive analyses of IgE in the blood of the umbilical cord, blood from the mother, and blood from the baby six months after birth.

"We discovered that approximately half of the tests with increased IgE levels in the umbilical blood were due to IgE from the mother," Dr. Klaus Bønnelykke, PhD says. "This may explain why many studies have showed poor results from the use of umbilical cord IgE. In future, if we want to use from the umbilical cord for to assess the risk of an infant developing asthma or allergy we need to take the transfer of IgE from the mother into account. Or we will need to find another method."

The discovery has been published in the Journal of Allergy and Clinical Immunology.

Explore further: Researcher discovers new method for creating bone tissue and cartilage tissue

Provided by University of Copenhagen

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Eliminating the source of asthma-causing immune molecules

May 10, 2010

Asthma and other allergic diseases are caused by inappropriate immune responses. Soluble IgE molecules, produced by immune cells known as B cells, are key immune mediators of these diseases. Therapeutic targeting of IgE in ...

Delayed cord clamping

Apr 16, 2008

Should you clamp the umbilical cord within a minute of birth or wait two or three minutes?

Munich researchers discover key allergy gene

Aug 22, 2008

Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment of the Technische Universität München, scientists at the Helmholtz Zentrum München have pinpointed a major ...

Recommended for you

Scientists image a beating heart in 3D (w/ Video)

1 hour ago

Researchers of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden report how they managed to capture detailed three-dimensional images of cardiac dynamics in zebrafish. The novel approach: ...

New device to monitor lung function in space

1 hour ago

A new method of collecting blood from the ear, currently part of an interactive exhibition at the Science Museum, could be used to monitor lung function in space. Less invasive, faster and more accurate than current methods, ...

Primate research center plays key role in HIV study in Nature

1 hour ago

In a study reported in Nature this month, Yerkes National Primate Research Center researchers were key in determining that treating SIV-infected rhesus macaques with type 1 interferon, a protein known to trigger antiviral respon ...

Three-people IVF debate process on the move in UK

3 hours ago

Takes two to make a child, correct? No. maybe. The use of sperm and eggs from three people to create babies moved a step closer in the UK, with Tuesday's events. What kind of egg-sperm distribution are we talking about? The ...

User comments : 0